Silibinin Protects Against Kidney Damage from Cisplatin
Author Information
Author(s): C Bokemeyer, LM Fels, T Dunn, W Voigt, J Gaedeke, H-J Schmoll, H Stolte, H Lentzen
Primary Institution: University of Tübingen
Hypothesis
Can silibinin protect against cisplatin-induced nephrotoxicity without affecting its anti-tumor activity?
Conclusion
Silibinin effectively reduces kidney toxicity caused by cisplatin while preserving its anti-tumor effects.
Supporting Evidence
- Silibinin significantly decreased kidney toxicity indicators in rats treated with cisplatin.
- Creatinine clearance was notably reduced in rats treated with cisplatin alone compared to those treated with silibinin and cisplatin.
- Urinary excretion of brush-border enzymes was significantly lower in the silibinin group.
Takeaway
Silibinin is like a shield for your kidneys when taking a strong medicine called cisplatin, helping to keep them safe while still fighting cancer.
Methodology
The study used a rat model to assess kidney function after administering silibinin and cisplatin, measuring various urinary and serum parameters.
Limitations
The study was conducted in a rat model, which may not fully replicate human responses.
Participant Demographics
Female Wistar rats aged between 170 and 230 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website